Updated Jul 16, 2026
Smaldone Alsup Laurie has filed 2 SEC Form 4 filings across 2 companies in the last 90 days.
Laurie Smaldone Alsup is a corporate insider who appears in Theravance Biopharma, Inc. SEC filings as of June 17, 2026. The available SEC context does not provide a clear, public biography or confirm a specific title (e.g., director or officer) beyond being listed among the company's insiders. Theravance Biopharma is a biotechnology company; beyond the 2026 SEC filing context, detailed public information about Ms. Alsup's career history, education, and notable achievements is not readily available from major public sources.
| Role | Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-26 | ARVN | ARVINAS, INC. | A — Grant or award | 15.5K | $0.00 | |
| 2026-06-17 | tbph | Theravance Biopharma, Inc. | A — Grant or award | 6.0K | $0.00 |
Laurie Smaldone Alsup is a corporate insider who appears in Theravance Biopharma, Inc. SEC filings as of June 17, 2026. The available SEC context does not provide a clear, public biography or confirm a specific title (e.g., director or officer) beyond being listed among the company's insiders. Theravance Biopharma is a biotechnology company; beyond the 2026 SEC filing context, …
2 primary Form 4 filings in the last 90 days, covering 2 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Smaldone Alsup Laurie profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.